Announced Mon, 18 May · 12:06 IST

Update on Disruption of Operations

Plant RestartedCapex & Operations View source PDF

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.6%1-day move
₹516.90
prior close
₹518.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.0+0.1+0.1+0.6-0.9+1.3+0.8+0.8+3.7+5.3+16.6+30.9
Up moveDown movePending
AI summary

Akums Drugs and Pharmaceuticals experienced a 4-day partial disruption at its Haridwar manufacturing sites in Uttarakhand, affecting production and causing delayed supply of approximately INR 20 Crores. The company clarified there was no property damage and no insurance claim will be filed. Operations have been fully restored to 100% capacity as of May 18, 2026. Management expects to recover the lost production within the coming weeks.

Likely market impact

The disruption appears to be temporary with minimal financial impact as operations are back to full capacity. The INR 20 Crore supply delay represents a small portion of business that management expects to recover soon, which should limit shareholder concerns.